ATE398611T1 - Para-amin substituierte phenylamid glukokinase activatoren - Google Patents
Para-amin substituierte phenylamid glukokinase activatorenInfo
- Publication number
- ATE398611T1 ATE398611T1 AT01943302T AT01943302T ATE398611T1 AT E398611 T1 ATE398611 T1 AT E398611T1 AT 01943302 T AT01943302 T AT 01943302T AT 01943302 T AT01943302 T AT 01943302T AT E398611 T1 ATE398611 T1 AT E398611T1
- Authority
- AT
- Austria
- Prior art keywords
- para
- amine substituted
- glucocinase
- activators
- substituted phenylamide
- Prior art date
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical class NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 1
- 239000012190 activator Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20238900P | 2000-05-08 | 2000-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE398611T1 true ATE398611T1 (de) | 2008-07-15 |
Family
ID=22749673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01943302T ATE398611T1 (de) | 2000-05-08 | 2001-04-30 | Para-amin substituierte phenylamid glukokinase activatoren |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1283830B1 (de) |
| JP (1) | JP3971189B2 (de) |
| KR (1) | KR100519826B1 (de) |
| CN (1) | CN1185220C (de) |
| AR (1) | AR030279A1 (de) |
| AT (1) | ATE398611T1 (de) |
| AU (2) | AU6591401A (de) |
| BR (1) | BR0110703A (de) |
| CA (1) | CA2407763C (de) |
| DE (1) | DE60134470D1 (de) |
| DK (1) | DK1283830T3 (de) |
| EC (1) | ECSP014062A (de) |
| ES (1) | ES2307623T3 (de) |
| MX (1) | MXPA02010795A (de) |
| PE (1) | PE20020049A1 (de) |
| PT (1) | PT1283830E (de) |
| UY (1) | UY26695A1 (de) |
| WO (1) | WO2001085707A1 (de) |
| ZA (1) | ZA200208503B (de) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610846B1 (en) | 1999-03-29 | 2003-08-26 | Hoffman-La Roche Inc. | Heteroaromatic glucokinase activators |
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| EP1724270A3 (de) | 2001-07-19 | 2007-01-03 | Pfizer Italia S.r.l. | Phenylacetamido-thiazole Verbindungen, Verfahren zu ihren Herstellung und ihre Anwendung als antitumor Mittel |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| EP1336607A1 (de) * | 2002-02-19 | 2003-08-20 | Novo Nordisk A/S | Amidderivate als Glucokinase-Aktivatoren |
| US6911545B2 (en) | 2001-12-19 | 2005-06-28 | Hoffman-La Roche Inc. | Crystals of glucokinase and methods of growing them |
| WO2003055482A1 (en) | 2001-12-21 | 2003-07-10 | Novo Nordisk A/S | Amide derivatives as gk activators |
| AU2003243921B2 (en) | 2002-06-27 | 2009-05-07 | Novo Nordisk A/S | Aryl carbonyl derivatives as therapeutic agents |
| KR101124245B1 (ko) | 2002-06-27 | 2012-07-02 | 노보 노르디스크 에이/에스 | 치료제로서 아릴 카르보닐 유도체 |
| MXPA05003559A (es) | 2002-10-03 | 2005-06-03 | Novartis Ag | (tiazol-2-il)-amida o sulfonamida substituida como activadores de glicocinasa utiles en el tratamiento de diabetes de tipo 2. |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| WO2004063194A1 (en) * | 2003-01-06 | 2004-07-29 | Eli Lilly And Company | Heteroaryl compounds |
| WO2004063179A1 (en) * | 2003-01-06 | 2004-07-29 | Eli Lilly And Company | Substituted arylcyclopropylacetamides as glucokinase activators |
| PL378117A1 (pl) | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
| PT1723128E (pt) | 2004-01-06 | 2013-02-27 | Novo Nordisk As | Heteroaril-ureias e o seu uso como activadores da glicoquinase |
| AU2005229416B2 (en) | 2004-04-02 | 2009-03-26 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes |
| KR20070006816A (ko) | 2004-04-02 | 2007-01-11 | 노파르티스 아게 | 티아졸로피리딘 유도체, 이를 함유하는 제약 조성물 및글루코키나제 매개형 증상의 치료 방법 |
| US8148412B2 (en) * | 2004-12-03 | 2012-04-03 | Novo Nordisk A/S | Heteroaromatic glucokinase activators |
| KR20080024211A (ko) | 2005-07-08 | 2008-03-17 | 노보 노르디스크 에이/에스 | 디시클로알킬 우레아 글루코키나제 활성제 |
| NZ564608A (en) | 2005-07-09 | 2009-09-25 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| US8106090B2 (en) | 2005-07-20 | 2012-01-31 | Eli Lilly And Company | 1-amino linked compounds |
| EP1921074A1 (de) | 2005-08-31 | 2008-05-14 | Astellas Pharma Inc. | Thiazolderivat |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| DK1951658T3 (da) | 2005-11-17 | 2012-10-15 | Lilly Co Eli | Glucagonreceptorantagonister, fremstilling og terapeutiske anvendelser |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| US8211925B2 (en) | 2006-04-28 | 2012-07-03 | Transtech Pharma, Inc. | Benzamide glucokinase activators |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
| MX2009000688A (es) | 2006-07-24 | 2009-01-30 | Hoffmann La Roche | Pirazoles como activadores de glucocinasa. |
| JP5419706B2 (ja) | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
| TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
| CN101622231B (zh) | 2007-02-28 | 2013-12-04 | 艾德维纳斯医疗私人有限公司 | 作为葡糖激酶激活剂的2，2，2-三取代的乙酰胺衍生物、它们的制造方法和药学应用 |
| WO2008116107A2 (en) * | 2007-03-21 | 2008-09-25 | Takeda San Diego, Inc. | Piperazine derivatives as glucokinase activators |
| WO2008156174A1 (ja) | 2007-06-21 | 2008-12-24 | Taisho Pharmaceutical Co., Ltd. | ピラジンアミド化合物 |
| EP2236498A4 (de) | 2008-01-18 | 2012-02-22 | Astellas Pharma Inc | Phenylacetamidderivat |
| US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
| US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
| HRP20150842T1 (hr) | 2008-04-28 | 2015-09-11 | Kyorin Pharmaceutical Co., Ltd. | Derivati ciklopentilakrilamida |
| EA018988B1 (ru) | 2008-05-16 | 2013-12-30 | Такеда Калифорния, Инк. | Активаторы глюкокиназы |
| UA104742C2 (uk) | 2008-12-19 | 2014-03-11 | Эли Лилли Энд Компани | Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази |
| KR101737151B1 (ko) | 2009-12-04 | 2017-05-17 | 닛산 가가쿠 고교 가부시키 가이샤 | 2-피리돈 화합물 |
| US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
| EP2553086B1 (de) | 2010-03-31 | 2017-04-19 | The Scripps Research Institute | Umprogrammierung von zellen |
| US8877794B2 (en) * | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| AU2019287437A1 (en) | 2018-06-12 | 2020-09-10 | Vtv Therapeutics Llc | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs |
| WO2021167840A1 (en) | 2020-02-18 | 2021-08-26 | Vtv Therapeutics Llc | Sulfoxide and sulfone glucokinase activators and methods of use thereof |
| CN116194442A (zh) | 2020-06-08 | 2023-05-30 | 维特卫治疗有限责任公司 | {2-[3-环己基-3-(反式-4-丙氧基-环己基)-脲基]-噻唑-5-基硫烷基}-乙酸的盐或共晶体及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4317320A1 (de) * | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
| US6011048A (en) * | 1997-01-28 | 2000-01-04 | Merck & Co., Inc. | Thiazole benzenesulfonamides as β3 agonists for treatment of diabetes and obesity |
-
2001
- 2001-04-30 DK DK01943302T patent/DK1283830T3/da active
- 2001-04-30 ES ES01943302T patent/ES2307623T3/es not_active Expired - Lifetime
- 2001-04-30 AT AT01943302T patent/ATE398611T1/de not_active IP Right Cessation
- 2001-04-30 JP JP2001582308A patent/JP3971189B2/ja not_active Expired - Fee Related
- 2001-04-30 KR KR10-2002-7014921A patent/KR100519826B1/ko not_active Expired - Fee Related
- 2001-04-30 CA CA002407763A patent/CA2407763C/en not_active Expired - Fee Related
- 2001-04-30 AU AU6591401A patent/AU6591401A/xx active Pending
- 2001-04-30 PT PT01943302T patent/PT1283830E/pt unknown
- 2001-04-30 CN CNB018092233A patent/CN1185220C/zh not_active Expired - Fee Related
- 2001-04-30 AU AU2001265914A patent/AU2001265914B2/en not_active Ceased
- 2001-04-30 BR BR0110703-8A patent/BR0110703A/pt not_active IP Right Cessation
- 2001-04-30 DE DE60134470T patent/DE60134470D1/de not_active Expired - Lifetime
- 2001-04-30 EP EP01943302A patent/EP1283830B1/de not_active Expired - Lifetime
- 2001-04-30 WO PCT/EP2001/004859 patent/WO2001085707A1/en not_active Ceased
- 2001-04-30 MX MXPA02010795A patent/MXPA02010795A/es active IP Right Grant
- 2001-05-02 PE PE2001000395A patent/PE20020049A1/es not_active Application Discontinuation
- 2001-05-04 AR ARP010102124A patent/AR030279A1/es unknown
- 2001-05-07 UY UY26695A patent/UY26695A1/es not_active Application Discontinuation
- 2001-05-08 EC EC2001004062A patent/ECSP014062A/es unknown
-
2002
- 2002-10-21 ZA ZA200208503A patent/ZA200208503B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200208503B (en) | 2004-01-22 |
| PT1283830E (pt) | 2008-08-18 |
| CN1185220C (zh) | 2005-01-19 |
| BR0110703A (pt) | 2003-01-28 |
| ES2307623T3 (es) | 2008-12-01 |
| CA2407763A1 (en) | 2001-11-15 |
| AU6591401A (en) | 2001-11-20 |
| UY26695A1 (es) | 2001-11-30 |
| AU2001265914B2 (en) | 2005-11-03 |
| JP3971189B2 (ja) | 2007-09-05 |
| MXPA02010795A (es) | 2003-03-27 |
| ECSP014062A (es) | 2002-02-25 |
| KR100519826B1 (ko) | 2005-10-06 |
| DE60134470D1 (de) | 2008-07-31 |
| DK1283830T3 (da) | 2008-08-25 |
| JP2003532719A (ja) | 2003-11-05 |
| EP1283830A1 (de) | 2003-02-19 |
| PE20020049A1 (es) | 2002-02-01 |
| EP1283830B1 (de) | 2008-06-18 |
| WO2001085707A1 (en) | 2001-11-15 |
| CN1427830A (zh) | 2003-07-02 |
| KR20020094019A (ko) | 2002-12-16 |
| CA2407763C (en) | 2007-04-24 |
| AR030279A1 (es) | 2003-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60134470D1 (de) | Para-amin substituierte phenylamid glukokinase activatoren | |
| DK1311504T3 (da) | Tetrazolyl-phenylacetamid-glucokinase-aktivatorer | |
| DE60014610D1 (de) | Glukokinase aktivatoren | |
| NO20022863D0 (no) | Trans-olefiniske glycokinase aktivatorer | |
| NO20032453L (no) | Substituerte imidazopyridiner | |
| DK1226127T3 (da) | Substituerede phenylsulfamoylcarboxamider | |
| DK1280801T3 (da) | Hydantoinholdige glucokinaseaktivatorer | |
| DE60114153D1 (de) | Substituierte arylpyrazine | |
| DE60133432D1 (de) | Biomaterial | |
| IS6599A (is) | 2-amínókarbónýl-9H-púrínafleiður | |
| AR028393A1 (es) | Iminoazidas substituidas | |
| DE60022980D1 (de) | Umgerührte Reibschweissverbindungen enthaltendes Bauelement | |
| ATE365721T1 (de) | Substituierte benzoylcyclohexenone | |
| ATE309983T1 (de) | Beta-thio-aminosäuren | |
| AR028302A1 (es) | Feniluracilos substituidos | |
| DE60122834D1 (de) | Torsions-Kipp-Komponente | |
| DE50113112D1 (de) | Schaltungsanordnung | |
| DE50105875D1 (de) | Bauteil | |
| FR2816595B3 (fr) | Palette | |
| DE60026622D1 (de) | Zerlegbare palette | |
| DE50115426D1 (de) | Schaltungsanordnung | |
| DE50107699D1 (de) | Bauelement | |
| ATA12432000A (de) | Bauelement | |
| FR2817889B1 (fr) | Coffrage | |
| PT1220852E (pt) | Diazepanos substituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1283830 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |